STAT News

FEBRUARY 13, 2023

Reed joined Sanofi in 2018, after holding a similar position at Swiss pharma company Roche. He was the eighth most highly-cited researcher in life sciences and medicine for the decade of 1995 to 2005, according to the Thomson Corporation. and a leading researcher in cell biology.

Life Science 98

Life Science Pharma Companies Medicine Research 98

Drug Discovery World

DECEMBER 6, 2023

The UK government has published new terms for the Statutory Scheme for branded medicines, which controls the prices of medicines paid by the NHS. This means that companies will pay a rebate on the sales of branded medicines to the NHS of 21.9% in 2024, 24% in 2025 and 26.8%

Life Science 59

Life Science Branding Medicine Pharma Companies 59

Delveinsight

JULY 21, 2021

However, some of the key pharma companies at the global level have shifted their focus towards these diverse diseases. Through this article, we have covered the major autoimmune diseases and the key companies striving to transform the treatment landscape of the respective disease.

Pharma Companies 94

Pharma Companies Marketing Insulin Development 94

World of DTC Marketing

JANUARY 24, 2022

To them, a big payday is a small biotech firm being acquired by a big ten pharma company. When they tell small biotech companies to cut costs, there will often be a significant delay in getting the drug to market or massive layoffs of needed staff. Venture capitalists often don’t look that far forward. Only about $2.2

Life Science 225

Life Science Drugs Genetic Disease Development 225

pharmaphorum

JANUARY 16, 2023

Two top pharma companies have exited the UK’s voluntary medicines pricing agreement in protest at what the industry has said is a “punitive” system of revenue clawbacks, casting doubt on the future of the scheme in its present form. In December, the ABPI warned that clawback – totalling almost £3.3

Life Science 69

Life Science Drugs Branding Medicine 69

XTalks

DECEMBER 20, 2023

As we step into 2024, the life sciences continue to evolve at an unprecedented pace, driven by technological innovation, a deeper understanding of human biology and the application of new technologies in areas like drug development and health wearables.

Life Science 119

Life Science Gene Editing Development Clinical Trials 119

World of DTC Marketing

JUNE 22, 2022

PBMs, insurers, pharma companies, and hospitals don’t want to give up their profits even if it’s better for the general population. The company has hired former senior health regulators to help it navigate America’s healthcare bureaucracy. .

Pharmacy 227

Pharmacy Generic Drugs Life Science Branding 227

pharmaphorum

SEPTEMBER 3, 2020

The area is being reimagined as a life sciences and technology hub and is already home to the Francis Crick Institute biomedical research organisation. With AI the pharma industry hopes to reduce the number of drugs that fail during the clinical development process, a huge financial drain on the industry.

Life Science 106

Life Science Engineer Scientist Pharma Companies 106

pharmaphorum

NOVEMBER 30, 2022

Veeva Systems invited pharmaphorum to attend its industry summit in Madrid this week, a huge event that gathered together over 1,000 individuals from life sciences and pharma. The question is, how can the journey there be accelerated, when on the horizon awaits a life sciences future very much immersed in speciality medicine?

Life Science 97

Life Science Pharma Companies Sales Marketing 97

Drug Discovery World

DECEMBER 14, 2023

The new centre represents a flagship investment within the University’s Glasgow Riverside Innovation District (GRID) and will be home to commercial businesses as well as the University of Glasgow-led Living Laboratory for Precision Medicine.

Drugs 75

Drugs Life Science Research Scientist 75

Drug Discovery World

FEBRUARY 10, 2023

Though not without its challenges, the life sciences industry in Scandinavia is well represented and acts as a serious contender for R&D output. More so, the Karolinska Institute is ranked at number seven in the world for the subjects of life sciences and medicine.

Life Science 52

Life Science Drugs Gene Therapy Manufacturing 52

Drug Discovery World

APRIL 27, 2023

The report notes that the focus on science and pharma throughout the Covid-19 pandemic has resulted in the emergence of new locations as life science hubs and name checks Boston, Massachusetts and San Francisco, California as examples of centres with heightened investment appeal in the life sciences 1.

Life Science 52

Life Science Drugs Research Gene Splicing 52

pharmaphorum

DECEMBER 16, 2020

Experts from Healthware Group explore how companies can rebuild their approach to digital from the ground up for the benefit of patients. Digital is not just a nice-to-have for pharma companies – it’s a necessity for ensuring that patients have the best possible outcomes in modern healthcare systems.

Life Science 59

Life Science Pharma Companies Sales Medicine 59

pharmaphorum

JANUARY 25, 2022

The Toronto-based company already counts many of the world’s largest pharma companies among its customers, using its platform for a range of tasks such as improving reagent and antibody selection to help scientists run more successful experiments, drawing on data from published studies and organisations’ internal databases.

Life Science 52

Life Science Pharma Companies Reagent Scientist 52

Drug Discovery World

MAY 22, 2023

Cell therapy, RNA technology, antibody drug conjugates and AI/machine learning are among the key areas of investment for pharma, according to a new report. Clarivate’s ‘Biopharma Dealmaking in 2023’ report examines how pharma companies are replenishing their pipelines as many face a steep patent cliff.

RNA 52

RNA Pharma Companies Antibody Life Science 52

pharmaphorum

FEBRUARY 1, 2022

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. But what does it take to implement these innovations? Mark holds a PhD in biomedicine, and an MSc in biostatistics.

Clinical Trials 96

Clinical Trials Clinical Trials Trials Engineer 96

pharmaphorum

OCTOBER 11, 2022

“Because digital permeates every aspect of the industry, and people are often talking about digital and maybe talking about very different things, I think about the journey of healthcare and life science companies in three stages,” he explained. The first stage of digital transformation was really all about communications.

Pharma Companies 92

Pharma Companies Medicine Doctors Doctor 92

Drug Discovery World

OCTOBER 16, 2023

Indeed, this is bolstered by top tier universities like Newcastle University, which specialises in structure-based approaches for drug discovery, developing innovative technologies that support the identification of new medicines, and is well-established in cancer drug discovery. Government investment of £1.3

Drugs 75

Drugs Life Science Gene Therapy Genome 75

pharmaphorum

NOVEMBER 23, 2022

A director in life sciences consulting for EY, she works within the commercial space for such companies, as well as their clients. “My However, it was around six or seven years ago that she began working specifically in pharma. There is still a struggle in pharma, an increasing demand for promotional materials.

Life Science 98

Life Science Marketing Medicine Production 98

pharmaphorum

MARCH 19, 2021

The oceans of health data out there can be overwhelming for pharma companies to manage – but if extracted correctly, the prospect to develop drugs from scratch in as little as a year is very real, says Lifebit CEO, Dr Maria Chatzou Dunford. . According to an article by Stephens, Zachary D., on Big data: astronomical or genomical? ,

Bioinformatics 59

Bioinformatics Drugs Genome Genomics 59

pharmaphorum

NOVEMBER 23, 2021

The DISC is the biggest investment AZ has ever made, and has been hailed by the pharma company’s chief executive Pascal Soriot as the centrepiece of what he believes could one day become a biotech hub to rival Boston and San Francisco in the US.

Gene Editing 105

Gene Editing Life Science Pharma Companies Clinical Trials 105

pharmaphorum

MARCH 2, 2022

There is a growing pipeline of psychedelic therapies and an expanding body of science to suggest that they may be able to provide an alternative to existing mental health treatments. A recent John Hopkins Medicine study showed that treatment with psilocybin relieved major depressive disorder for at least a year for certain patients.

Life Science 102

Life Science Clinical Trials Clinical Trials Trials 102

Pharmaceutical Technology

JANUARY 31, 2023

Inflation Reduction Act Speaking during the keynote panel “FDA & ARPA-H: Life Sciences, Biopharma & Medtech Priorities in a New Year”, Califf discussed the Inflation Reduction Act of August 2022, which aims to lower prescription drug prices. That leaves three years for pharma companies to prepare. It’s a hot area.”

Drugs 130

Drugs Regulation Gene Therapy Insulin 130

XTalks

OCTOBER 4, 2023

But we have a group of products in areas such as oncology, specialized medicine and cell and gene therapies, where traditional frameworks for drug reimbursement decision-making pose challenges both for manufacturers of innovative medicines and for drug reimbursement decision-makers. And there are a couple of reasons for that.

Marketing 105

Marketing Development Drugs Gene Therapy 105

XTalks

DECEMBER 22, 2021

If the past year is anything to go by, then 2022 will also be a year marked by continued innovations in the life sciences. Here is a look at some life science trends to expect in the coming year, including key themes and topics in the pharmaceutical, biotechnology and medical device industries to keep an eye out for in 2022.

Life Science 98

Life Science RNA Vaccination Vaccine 98

pharmaphorum

SEPTEMBER 15, 2020

For pharma companies, COVID-19 has proved that they can be agile and responsive to rapidly evolving market conditions, as evidenced by the way they have adjusted to a new global paradigm while successfully continuing operations. Preparing for an agile pharma future. About the interviewees.

Branding 114

Branding Marketing Pharma Companies Life Science 114

pharmaphorum

MARCH 23, 2021

With diverse applications and approaches, it is quickly becoming a promising tool for patient adherence, chronic disease management, preventive medicine, rehabilitation, and paediatric care, as well as for medical education, training, event engagement, and more. However, it is proving more than a mere buzzword. Medical education.

Pharma Companies 142

Pharma Companies Medicine Life Science 142

pharmaphorum

JANUARY 5, 2023

With the increasing convergence of technology and life sciences, search for personable candidates who can pair tech-enabled solutions to patient-centered medicine. Prioritise professional development: With a scarcity of skilled labour, now is the time for pharma companies to tap into their greatest assets – their people.

Life Science 71

Life Science Pharmacy Marketing Sales 71

Pharma Marketing Network

FEBRUARY 10, 2022

Experts from top life sciences companies discussed strategies for more effectively engaging oncologists at the Pharma Marketing Network’s 2022 Future Forecast on January 25 th. Instead, he said that “innovation for the sake of utility” can help pharma companies maximize the impact of their digital marketing activities.

Branding 98

Branding Marketing Life Science Pharma Companies 98

XTalks

MARCH 28, 2024

Bettica said the company’s focus is to now “make Duvyzat available as a treatment for DMD management in the US as quickly as possible.” McDonald, MD, professor at the Department of Pediatrics and Physical Medicine Rehabilitation at the University of California Davis Health and investigator for the EPIDYS trial.

FDA Approval 105

FDA Approval Genetics Gene Therapy Gene 105

Drug Discovery World

JULY 18, 2022

Troy Groetken of intellectual property and technology law firm McAndrews, Held & Malloy tells Lu Rahman how pharma companies can take this data from where it currently stands (drug design and development) to a more clinical level. Groetken sees many opportunities to utilise big data and AI in pharma. Regulatory issues.

Big Data 52

Big Data Life Science Development Clinical Trials 52

pharmaphorum

DECEMBER 15, 2022

Co-chaired by Lord James O’Shaughnessy and Professor Mike Bewick, former deputy national medical director of NHS England (present online), the NHS Innovation and Life Sciences Commission Report launch took place at One Great George Street, Westminster, on 12th December 2022. With that, he had to go vote.

Life Science 90

Life Science Medicine Clinical Trials Clinical Trials 90

Drug Discovery World

OCTOBER 6, 2022

This growth is due to factors including a rise in speciality medicines, an increase in lifestyle-driven diseases and a growing population 1. Data from the BioIndustry Association (BIA) and Clarivate 4 shows 2021 was the highest year on record for investments into UK biotech and life sciences companies. Valued at $14.8

Development 52

Development Drugs Life Science Marketing 52

pharmaphorum

MAY 27, 2022

This is the second in a two-part series examining how pharma can embrace the DEI agenda to create more effective medicines through more representative clinical trials. There is a huge opportunity for pharma companies to capitalise on by focusing on increased DEI in clinical trials. What comes next? About the interviewees.

Clinical Trials 80

Clinical Trials Clinical Trials Trials Packaging 80

XTalks

JANUARY 5, 2024

Eli Lilly launched LillyDirect this week, an online service that provides access to the company’s medicines, including its newly approved weight loss drug Zepbound (tirzepatide). Ricks, Lilly’s chair and CEO, in the company’s announcement. Zepbound was approved by the US Food and Drug Administration (FDA) in November 2023.

Drugs 59

Drugs Pharmacy Cosmetics Insulin 59

XTalks

AUGUST 21, 2023

“The FDA approval of Sohonos is a breakthrough for the US FOP community,” said Howard Mayer, head of R&D at Ipsen, in the company’s news release. Development of medicines for rare diseases takes commitment and belief from everyone involved.

Drugs 98

Drugs FDA Approval Genetics Clinical Trials 98

pharmaphorum

MARCH 26, 2021

The UK Government and EU Commission trumpeted their Brexit trade deal, struck at the end of December, as ‘comprehensive’, the ‘biggest yet’ But a closer inspection of the EU-UK Trade and Cooperation Agreement (TCA) renders these statements largely illusory for the pharma sector. Medical devices do not feature at all.

Production 101

Production Medicine Marketing Regulation 101